Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
AIDS Res Hum Retroviruses
    November 2025
  1. BACHELARD A, Julia Z, Damond F, Barral T, et al
    Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1-Infected Pregnant Women: Real-Life Use.
    AIDS Res Hum Retroviruses. 2025 Nov 17. doi: 10.1177/08892229251398861.
    >> Share

    September 2025
  2. MADLALA HP, Myer L, Geffen H, Jao J, et al
    Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African Women.
    AIDS Res Hum Retroviruses. 2025 Sep 3. doi: 10.1177/08892229251374692.
    >> Share

    July 2025
  3. HASEBE S, Tanaka M, Iwane S, Tsuji T, et al
    Comprehensive Cardiovascular Risk Profiling in People Living with HIV: Insights from the Japanese Adverse Drug Event Report Database.
    AIDS Res Hum Retroviruses. 2025 Jul 11. doi: 10.1177/08892229251359555.
    >> Share

    June 2025
  4. VANGELOV D, Emilova R, Todorova Y, Alexiev I, et al
    Genetic Signatures of Immune Recovery in People Living with HIV on Long-Term Contemporary Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2025 Jun 9. doi: 10.1089/aid.2024.0111.
    >> Share

    April 2025
  5. WANG L, Yan M, Wumaierjiang R, Zhang Q, et al
    The Association Between the History of Switching Antiretroviral Therapy Regimens and Lipid Profile in People Living with HIV: A Retrospective Study.
    AIDS Res Hum Retroviruses. 2025 Apr 7. doi: 10.1089/aid.2024.0079.
    >> Share

    February 2025
  6. CHO YK, Lee J
    Impact of INSTI on a Drug-Resistant Mutation (S68S Insertion) in a Patient Infected with HIV-1 CRF06_cpx.
    AIDS Res Hum Retroviruses. 2025 Feb 3. doi: 10.1089/aid.2024.0107.
    >> Share

    January 2025
  7. CAO B, Liu M, Song S, Guo M, et al
    HIV-1 DNA Genotypic Drug Resistance Testing Guides Antiretroviral Therapy in Patients with Low-Level Viremia.
    AIDS Res Hum Retroviruses. 2025 Jan 15. doi: 10.1089/aid.2024.0088.
    >> Share

    October 2024
  8. CICCULLO A, Iannone V, Farinacci D, Steiner RJ, et al
    Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.
    AIDS Res Hum Retroviruses. 2024 Oct 29. doi: 10.1089/aid.2024.0066.
    >> Share

  9. FOGEL JM, Persaud D, Piwowar-Manning E, Richardson P, et al
    HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.
    AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0049.
    >> Share

    July 2024
  10. RODRIGUEZ-LOPEZ E, Lopez P, Rodriguez Y, Sanchez R, et al
    HIV-1 integrase T218I/S polymorphisms do not reduce HIV-1 integrase inhibitors' phenotypic susceptibility.
    AIDS Res Hum Retroviruses. 2024 Jul 31. doi: 10.1089/AID.2023.0128.
    >> Share

  11. ROSS LL, Cotton M, Cassim H, Garges HP, et al
    Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living With HIV-1 Treated With Ritonavir-Boosted Fosamprenavir Oral Solution-Based Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2024 Jul 8. doi: 10.1089/AID.2024.0020.
    >> Share

  12. BYRNE M, Resnik J, Horberg M, Greenberg AE, et al
    Factors associated with time to initial antiretroviral regimen discontinuation in the DC Cohort.
    AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0002.
    >> Share

    May 2024
  13. CAO B, Wu C, Liu M, Song S, et al
    Molecular transmission network and drug resistance in treatment-naive HIV-1 infected patients in the Liangshan District, China.
    AIDS Res Hum Retroviruses. 2024 May 24. doi: 10.1089/AID.2024.0016.
    >> Share

  14. GUO L, Fu Y, Xie X, Yan W, et al
    Comparative on the Efficacy and Safety of ANV-Based Versus EFV-Based ART in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China.
    AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0030.
    >> Share

    March 2024
  15. WOHLFEILER MB, Weber RP, Brunet L, Siddiqui J, et al
    Incident HIV-Associated Wasting/Low Weight is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
    AIDS Res Hum Retroviruses. 2024 Mar 14. doi: 10.1089/AID.2023.0113.
    >> Share

    February 2024
  16. LAUFER N, Bouzas MB, Fernandez-Giuliano S, Zapiola I, et al
    Pretreatment HIV-1 Resistance in Argentina: results from the second surveillance study following WHO guidelines (2019).
    AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0083.
    >> Share

    January 2024
  17. MANGALA C, Maulot-Bangola D, Moutsinga A, Wamba AG, et al
    CURRENT RESISTANCE OF HIV-1 STRAINS ISOLATED IN VOLUNTEER BLOOD DONORS IN GABON.
    AIDS Res Hum Retroviruses. 2024 Jan 2. doi: 10.1089/AID.2023.0080.
    >> Share

    December 2023
  18. PUJARI S, Gaikwad S, Panchawagh S, Chitalikar A, et al
    Effectiveness, weight changes and metabolic outcomes on switch to generic dolutegravir/lamivudine amongst people with HIV in Western India: An observational study.
    AIDS Res Hum Retroviruses. 2023 Dec 8. doi: 10.1089/AID.2022.0167.
    >> Share

    November 2023
  19. DONG S, Lu X, Wang Y, An N, et al
    Near-full-length genome analysis of a HIV-1 CRF01_AE/B recombinant strain among men who have sex with men in Chengde City, China.
    AIDS Res Hum Retroviruses. 2023 Nov 19. doi: 10.1089/AID.2023.0110.
    >> Share

    July 2023
  20. FARINACCI D, Iannone V, D'Angelillo A, Borghetti A, et al
    TWO-DRUG REGIMEN CONTAINING DARUNAVIR. METABOLIC EVALUATION OF AN OLD DUAL THERAPY.
    AIDS Res Hum Retroviruses. 2023 Jul 6. doi: 10.1089/AID.2023.0023.
    >> Share

    June 2023
  21. CALZA L, Colangeli V, Legnani G, Cretella S, et al
    EFFICACY AND SAFETY OF SWITCHING TO DOLUTEGRAVIR/LAMIVUDINE IN VIROLOGICALLY SUPPRESSED PEOPLE LIVING WITH HIV-1 AGED OVER 65 YEARS.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0046.
    >> Share

  22. LEE EH, Lee JA, Kim CH, Lee KH, et al
    Pentraxin 3 as an immune recovery marker in HIV infection after combination antiretroviral therapy.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0002.
    >> Share

  23. PATEL Y, Doshi A, Levesque A, Lindor S, et al
    Weight Gain in People with HIV: The role of demographics, antiretroviral therapy, and lifestyle factors on weight.
    AIDS Res Hum Retroviruses. 2023 Jun 5. doi: 10.1089/AID.2023.0008.
    >> Share

    May 2023
  24. CAO B, Liu M, Jiang T, Yu Q, et al
    HIV-1 RNA and DNA genotyping drug resistance detection in patients with low-level viremia in Liangshan, China.
    AIDS Res Hum Retroviruses. 2023 May 14. doi: 10.1089/AID.2022.0140.
    >> Share

  25. LAHIRI CD, Mehta CC, Sykes C, Weiser SD, et al
    Obesity Modifies the Relationship Between Raltegravir and Dolutegravir Hair Concentrations and Body Weight Gain in Women Living with HIV.
    AIDS Res Hum Retroviruses. 2023 May 4. doi: 10.1089/AID.2022.0185.
    >> Share

    April 2023
  26. PEREZ BARRAGAN E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al
    Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2022.0130.
    >> Share

  27. ATKINSON B, Abbasi A, Sajadi MM, Tehrani ZR, et al
    Replacement of ART with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer.
    AIDS Res Hum Retroviruses. 2023 Apr 13. doi: 10.1089/AID.2022.0181.
    >> Share

  28. DU R, Huang J
    Machine learning revealed a novel ferroptosis-based classification for diagnosis in antiretroviral therapy-treated HIV patients with defective immune recovery.
    AIDS Res Hum Retroviruses. 2023 Apr 8. doi: 10.1089/AID.2022.0138.
    >> Share

    February 2023
  29. OOMEN PGA, Hakkers CS, Arends J, van den Berk G, et al
    The effect of efavirenz on reward processing in asymptomatic people living with HIV: a randomized controlled trial.
    AIDS Res Hum Retroviruses. 2023 Feb 3. doi: 10.1089/AID.2022.0069.
    >> Share

    January 2023
  30. BELAUNZARAN-ZAMUDIO PF, Naranjo L, Caro-Vega Y, Castillo-Mancilla JR, et al
    Incomplete ART Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV-infection in Mexico.
    AIDS Res Hum Retroviruses. 2023 Jan 3. doi: 10.1089/AID.2021.0179.
    >> Share

    December 2022
  31. WALMSLEY S, Clarke R, Lee T, Singer J, et al
    BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Peri-menopausal period.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0106.
    >> Share

  32. MISHRA S, Taneja S, De A, Verma N, et al
    Efficacy, tolerability and compliance of direct acting antivirals in patients with HIV and Hepatitis C co-infection: A real-life experience.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0034.
    >> Share

    November 2022
  33. LEAL L, Guardo AC, Bedoya LM, Rodriguez de Miguel C, et al
    Pharmacokinetics, the immunological impact and the effect on HIV ex-vivo infectivity of maraviroc, raltegravir and lopinavir in MSM using Post-exposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2022 Nov 23. doi: 10.1089/AID.2021.0232.
    >> Share

  34. MOSCHOPOULOS C, Protopapas K, Thomas K, Kavatha D, et al
    Switching from tenofovir disoproxil to tenofovir alafenamide fumarate: Impact on cardiovascular risk and lipid profile in people living with HIV, an observational single-center study.
    AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0086.
    >> Share

  35. FAILLA M, Pasquali E, Galli L, Chiappini E, et al
    Integrase strand transfer inhibitors use in children with perinatal HIV-1 infection: a narrative review.
    AIDS Res Hum Retroviruses. 2022 Nov 9. doi: 10.1089/AID.2022.0039.
    >> Share

    October 2022
  36. ADACHI E, Ikeuchi K, Koga M, Yotsuyanagi H, et al
    Changes in inflammatory biomarkers when switching from from 3-drug regimens to dolutegravir plus lamivudine in people living with HIV.
    AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2022.0115.
    >> Share

  37. ANDRADE A, Fuchs EJ, Marzinke MA, Abdul Massih S, et al
    EVG/COBI/FTC/TAF BIOEQUIVALENCE COMPARING WHOLE TABLETS TO TABLETS DISSOLVED IN TAP WATER.
    AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2022.0085.
    >> Share

  38. GRINSTEINER E, Morrow M, MaWhinney S, Coyle R, et al
    Demographic and clinical characteristics of persons with HIV with viral load:adherence mismatch who are at risk of future viremia.
    AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2021.0218.
    >> Share

  39. ZHOU XY, Li CX, Zhang JB, Tan JT, et al
    Association of human leukocyte antigen alleles and hypersensitivity of Efavirenz/Nevirapine in HIV-infected Chinese patients.
    AIDS Res Hum Retroviruses. 2022 Oct 13. doi: 10.1089/AID.2022.0027.
    >> Share

    September 2022
  40. ZHAO R, Ma R, Zhao C, Zhang Q, et al
    Risk factors for Osteonecrosis of the femoral head in HIV positive patients: A retrospective case-control study.
    AIDS Res Hum Retroviruses. 2022 Sep 27. doi: 10.1089/AID.2021.0224.
    >> Share

    August 2022
  41. KOUAMOU V, Machekano R, Mapangisana T, Maposhere C, et al
    Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.
    AIDS Res Hum Retroviruses. 2022 Aug 12. doi: 10.1089/AID.2021.0140.
    >> Share

  42. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
    Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.
    AIDS Res Hum Retroviruses. 2022 Aug 9. doi: 10.1089/AID.2022.0043.
    >> Share

  43. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Excessive weight gain: current antiretroviral agents in virologically suppressed people with HIV.
    AIDS Res Hum Retroviruses. 2022 Aug 3. doi: 10.1089/AID.2021.0188.
    >> Share

    July 2022
  44. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
    Gender-affirming hormone pharmacokinetics among adolescent and young adult transgender persons receiving daily F/TDF.
    AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2022.0044.
    >> Share

  45. SIDDIQUI M, Moore TJ, Long DM, Burkholder GA, et al
    Risk factors for incident hypertension within one year of initiating antiretroviral therapy among people with HIV.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0213.
    >> Share

  46. TOEQUE MG, Lindsay B, Zulu PM, Hachaambwa L, et al
    Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0208.
    >> Share

    April 2022
  47. NARVAEZ M, Lins-Kusterer L, Valdelamar-Jimenez J, Brites C, et al
    Quality of life and antiretroviral therapy adherence: A cross-sectional study in Colombia.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0233.
    >> Share

    March 2022
  48. RUBIN L, Neijna A, Shi Q, Hoover DR, et al
    Degree of polypharmacy and cognitive function in older women with HIV.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0231.
    >> Share

  49. RUIZ-ALGUERO M, Alejos B, Garcia Yubero C, Riera Jaume M, et al
    Use of generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection in Spain.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0122.
    >> Share

  50. KARUNAIANANTHAM R, Nesakumar M, Gopalan B, Haribabu H, et al
    Molecular characterisation of the pol gene of vertically transmitted HIV-1 strains in children with virological failure.
    AIDS Res Hum Retroviruses. 2022 Mar 18. doi: 10.1089/AID.2021.0227.
    >> Share

  51. MCLIGEYO A, Wekesa P, Owuor K, Mwangi J, et al
    Factors associated with treatment outcomes among children and adolescents living with HIIV receiving antiretroviral therapy in central Kenya.
    AIDS Res Hum Retroviruses. 2022 Mar 1. doi: 10.1089/AID.2021.0112.
    >> Share

    April 2021
  52. SIYAN C, Qihua X, Jian W, Xinghua T, et al
    Effects of artesunate tablet on immune activation and reconstitution among HAART-treated patients with incomplete immune responses.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0254.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016